No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
www.financiere-tubize.beNo one on the platform currently holds TUB.BR.
No tracked institution reports a position in TUB.BR as of their last filing.
No one on the platform has traded TUB.BR yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| TUB.BRFinancière de Tubize S.A. | $176.90 | -0.62% | $7.9B | — |
| ALEMS.BREuropean Medical Solutions | $4.24 | +7.07% | $18M | — |
| BIOS.BRBioSenic S.A. | $0.00 | +0.00% | $1M | — |
| CYAD.BRCelyad Oncology S.A. | $0.24 | -8.75% | $11M | — |
| FAGR.BRFagron N.V. | $22.10 | +1.61% | $1.6B | — |
| HYL.BRHyloris Pharmaceuticals S.A. | $4.25 | +0.24% | $119M | — |
| IBAB.BRIon Beam Applications S.A. | $15.38 | -0.26% | $451M | — |
Source: Financial Modeling Prep · peers by sector/industry